Introduction and background {#sec1}
===========================

The knee is the most commonly affected joint by osteoarthritis (OA) [@bib1]. In the evaluation of knee OA, it becomes important to define which compartments are being affected. Medial compartment OA is 5-10 times more common than lateral compartment OA in North America [@bib2]. In varus knee OA, cadaver and radiographic studies have shown that knee OA typically progresses in predictable fashion from medially to laterally [@bib3]. As such, the 2 compartments that initially present symptomatically include the medial tibiofemoral compartment and the patellofemoral compartment.

Currently, the standard of treatment for bicompartmental OA of the medial and patellofemoral compartments, that has failed conservative treatment, is total knee arthroplasty (TKA). Despite its advantages and well-documented track record, TKA can also have many drawbacks in this setting as well. TKA sacrifices the unaffected lateral compartment as well as one or more cruciate ligaments, causing disruption of normal knee kinematics and gait [@bib4]. In addition, total knee components often require a greater amount of bone stalk, making revision scenarios more difficult. As younger patients are now presenting with isolated compartmental OA, and older patients are living increasingly longer and active lifestyles, the need for an alternative prosthesis that address these issues has become more pertinent. For these reasons, unicompartmental knee arthroplasty has seen a resurgence in its use because of its quicker rehabilitation times, decreased morbidity, and preservation of normal knee kinematics [@bib5]. Unfortunately, bicompartmental OA is a contraindication for unicompartmental knee arthroplasty as a diseased patellofemoral compartment increases risk of revision [@bib6].

In light of these issues, interest in bicompartmental knee arthroplasty (BKA) for the treatment of medial patellofemoral osteoarthritis (MPFOA) has grown in recent years. Two different categories of implants are currently being used for BKA, which include monolithic and modular components [@bib4]. These monolithic implants use a single contoured femoral component to resurface the medial and patellofemoral compartments, whereas modular implants use separate components to resurface both compartments. Nonetheless, these BKA implants offer a bone and ligament preserving procedure that only resurfaces the diseased compartments [@bib7]. Retention of both cruciate ligaments theoretically preserves proprioception, and maintains native knee kinematics. Several recent biomechanical studies have demonstrated this principle in BKA, showing improvement in 3-dimensional joint kinematics and gait analysis, which is comparable with healthy controls [@bib8], [@bib9]. However, it is still unclear if these theoretical and biomechanical advantages will translate into significant clinical differences.

The objective of this study, therefore, is to assess knee function and perioperative morbidity in patients undergoing BKA vs TKA for MPFOA. Several recent clinical and observational studies have recently published on this topic, albeit with varying results, which we will further analyze with a meta-analysis. We hypothesize that BKA will be superior to TKA in terms of clinical and functional benefits.

Material and methods {#sec2}
====================

A systematic literature search was completed by a single reviewer (S. K.) at the University of Calgary. This search was completed and is up to date as of September 11, 2015. The databases MEDLINE, PUBMED, and EMBASE were searched using engine specific strategies unique to each database to maximize sensitivity ([Appendix 1](#appsec1){ref-type="sec"}). References of each study, and related citations on each search engine, were explored for any potentially eligible studies. All search results were then compiled in an online database, and duplicates were deleted. Studies were then scanned based on title and abstract for eligibility. Studies that were thought to be eligible then underwent full text review, after which only primary articles, which met all the inclusion and exclusion criteria, were included in the meta-analysis. Two reviewers selected the trails to be included from the compiled literature search (S. K. and H. J.). Disagreements were resolved by consensus, and by a third reviewer if needed. Risks of bias for each included study were then systematically evaluated using the GRADE approach as outlined in the Cochrane Handbook for Systematic Reviews [@bib10].

Eligibility for studies included randomized controlled trials or nonrandomized comparative studies. Population-specific eligibility requirements included adult patients undergoing primary BKA for MPFOA. The intervention evaluated in the trials had to compare BKA with TKA, with a follow-up period of at least 2 years. Studies were excluded if BKA was performed for lateral compartment OA, or if it was not specified whether patients had BKA for MPFOA. Studies were also excluded if knee arthroplasty was performed for reasons other than primary OA, including inflammatory arthropathies or arthroplasty revision. Studies were not excluded based on the type or brand of BKA or TKA being used.

The primary outcome of interest was postoperative knee function, measured using validated scoring questionnaires, such as the Knee Society Score (KSS), Knee Injury and Osteoarthritis Outcome score (KOOS), Western Ontario and McMaster Universities Arthritis Index (WOMAC), etc. Secondary outcomes included range of movement, postoperative pain, operation length, intraoperative blood loss, hospital length of stay, postoperative complications (infection, stiffness, deep vein thrombosis and/or pulmonary embolism, etc.), health-related quality of life measures, and rate of revision and reoperation.

A data extraction form, which included authors, publication date, study design, patient\'s characteristics, implant type, and specific outcome measurements, was developed to collect data from the selected studies. Meta-analysis was then performed by pooling the results of selected studies when possible using Review Manager 5.3. Continuous data were entered as means and standard deviations, and dichotomous outcomes as number of events or odd ratio. Statistical analysis was performed by comparing mean differences (MDs) of two or more studies when results were collected using similar measures, or standardized MD when results were collected in a heterogeneous manner. In the case of missing data, standard deviations were calculated based on the "*P*" value, after finding a corresponding "*t*" value and inputting it into the formula standard error = MD/*t*. If the *P* value was not specified or given, standard deviations were inputted from comparable studies. Similarly, if outcomes were reported as median and range, they were converted to mean and standard deviation using the formula in [Appendix 2](#appsec1){ref-type="sec"} [@bib11]. A random-effects model was used for all analysis. Data were reported as MD with 95% confidence intervals. Heterogeneity was assessed initially by visual inspection of the forest plots. In addition, an I^2^ statistic was used to quantify risk of heterogeneity between studies. A *P* \> .1 and an I^2^ ≤50% were considered of no statistical heterogeneity.

Results {#sec3}
=======

Our literature search produced 150 references, after which 79 remained when duplicates were removed. After the initial screening review, 7 studies where chosen to undergo full text review. One study was excluded for including patients who had undergone BKA for lateral compartment OA [@bib12]. In total, 6 studies were selected for inclusion in the meta-analysis, as shown in the PRISMA flow diagram ([Fig. 1](#fig1){ref-type="fig"}) [@bib13], [@bib14], [@bib15], [@bib16], [@bib17], [@bib18]. A kappa value of 0.9 was determined based on the selections of two reviewers (S. K. and H. J.), indicating excellent agreement between authors. Four of these studies were prospective in nature (2 randomized controlled trials, 1 pseudorandomized, and 1 nonrandomized prospective cohort), and 2 were retrospective cohort studies. In addition, 4 studies used modular BKA implant, whereas 2 used a monolith BKA design. In total, 274 patients and 277 knees were included for analysis, which included 133 primary BKAs and 144 primary TKAs. The average age of participants in the included studies ranged from 52.1-68.18 years; average BMI ranged from 26-33.7 kg/m^2^; and follow-up period ranged from 2-5 years ([Table 1](#tbl1){ref-type="table"}). In terms of gender, 68.5% of BKA patients were women, and 71.4% of TKA patients were women. The most commonly reported outcome scores included flexion and/or range of movement, KSS, KOOS, WOMAC, and Short-Form 36 (SF-36).Figure 1PRISMA flow diagram.Table 1Included study characteristics.StudyDesignLevelImplant*N*AgeGender (female:male)BMIFollow-Up, yComplicationsRevisionsBKATKABKATKABKATKABKATKABKATKABKATKAParratte et al. 2015 [@bib13]PseudorandomizedIIAModular343461 (7)61 (8)21:1321:1327.5 (4)27.5 (4.5)3.8 (1.7)0101Yeo et al. 2015 [@bib16]RCTIModular222063.8 (8.03)63.1 (7.34)21:516:627.28 (3.04)28.15 (4.52)6 m, 1, 2, 51010Engh et al. 2014 [@bib18]RCTIMonolith252560.358.328.8301 m, 4 m, 1, 21331Tan et al. 2013 [@bib14]Retrospective cohortIIBModular1512526010:57:526 (4.2)28.3 (4.9)6 m, 1, 20000Shah et al. 2013 [@bib15]Retrospective cohortIIBModular162052.1 (6.4)65.1 (7.5)10:616:427.6 (4.4)27.3 (3.8)6 m, 1, 21000Morrison et al. 2011 [@bib17]Prospective cohortIAMonolith213363.2 (11.5)67.18 (9.5)14:625:631.7 (7.7)33.7 (8.6)3 m, 1, 23230Total13314476:3585:346672[^1][^2]

The quality of evidence was evaluated using the GRADE approach described in the Cochrane Handbook for Systematic Reviews of Intervention. The risk of bias was variable between studies, but all 6 studies included were of moderate to high quality evidence with low to moderate risk of bias ([Fig. 2](#fig2){ref-type="fig"}). Clinical trials were found to have the lowest risk of bias, whereas the nonrandomized prospective cohort and retrospective cohort studies were found to have the highest risk of bias.Figure 2GRADE risks of bias for included studies.

A total of 24 subgroup analyses were completed. Our meta-analysis did not show any significant differences between BKA vs TKA for flexion, KSS knee, KSS function, KOOS pain, KOOS symptoms, KOOS activity in daily living, SF-36 mental, or SF-36 physical at any period ([Table 2](#tbl2){ref-type="table"}). However, BKA did have a significantly lower WOMAC pain score at 1 year (MD = −8.09, 95% confidence interval \[CI\] −3.21 to 12.98, *P* = .001) and 2 years (MD = −6.07, 95% CI −0.83 to −11.31, *P* = .02) compared with TKA, indicating worse pain control in the TKA group. During our analysis, it became clear that monolith implants had a higher revision rate due to increased pain and prosthesis fracture. As such, a sensitivity analysis was performed by removing any studies that used a monolithic BKA implants. This sensitivity analysis did not demonstrate any differences between BKA vs TKA for any of the clinical or functional outcome score questionnaires at any time points.Table 2Subgroup meta-analysis.SubgroupStudiesParticipantsMD \[95% CI\]I^2^*P*Knee Flexion (6 mo)2788.77 \[−7.64, 25.18\]88.29Knee Flexion (1 y)2785.50 \[−10.66, 21.66\]87.5Knee Flexion (2 y)31466.21 \[−1.72, 14.14\]75.12KSS Knee (3-6 mo)31552.14 \[−1.37, 5.65\]10.23KSS Knee (1 y)3105−1.80 \[−6.58, 2.98\]0.46KSS Knee (2 y)52231.15 \[−3.48, 5.78\]72.63KSS Function (3-6 mo)3105−1.89 \[−7.52, 3.73\]0.51KSS Function (1 y)31051.46 \[−3.92, 6.83\]0.6KSS Function (2 y)41733.36 \[−2.70, 9.43\]69.28KOOS Pain (2 y)2104−0.32 \[−10.99, 10.36\]85.95KOOS Symptoms (2 y)21041.61 \[−3.13, 6.36\]77.51KOOS activity in daily living (2 y)21041.34 \[−7.74, 10.42\]59.77Length of Stay (d)269−0.38 \[−1.33, 0.57\]66.43SF-36 Mental (6 mo)2692.27 \[−0.80, 5.33\]0.15SF-36 Mental (1 y)2697.37 \[−6.92, 21.66\]91.31SF-36 Mental (2 y)269−0.21 \[−3.60, 3.17\]0.9SF-36 Physical (6 mo)269−8.34 \[−21.67, 4.98\]95.22SF-36 Physical (1 y)269−2.61 \[−6.38, 1.15\]0.17SF-36 Physical (2 y)269−1.87 \[−4.62, 0.89\]0.18WOMAC Pain (3-6 mo)2906.19 \[−11.52, 23.89\]86.49WOMAC Pain (1 y)290−8.09 \[−12.98, −3.21\]10.001[a](#tbl2fna){ref-type="table-fn"}WOMAC Pain (2 y)290−6.07 \[−11.31, −0.83\]0.02[a](#tbl2fna){ref-type="table-fn"}Operation Length (min)26316.58 \[8.59, 24.58\]0\<.0001[a](#tbl2fna){ref-type="table-fn"}Intraoperative Blood Loss (g/L)269−9.11 \[−13.34, −4.88\]28\<.0001[a](#tbl2fna){ref-type="table-fn"}[^3][^4]

In terms of secondary outcomes, BKA resulted in significantly less intraoperative blood loss compared with TKA (MD = −9.11 g/L, 95% CI −4.88 to −13.34, *P* \< .0001; [Fig. 3](#fig3){ref-type="fig"}). Nonetheless, BKA also significantly increased operation length compared with TKA (MD = 16.58 minutes, 95% CI 8.59-24.58, *P* \< .0001; [Fig. 4](#fig4){ref-type="fig"}). The number of complications, 6, was equal between both groups. The BKA group had 2 instances of manipulation under anesthesia, 2 instances of patellar subluxation (1 of which required an arthroscopic release), 1 superficial infection, and 1 patellar fracture. In the TKA group, complications included 3 instances of manipulation under anesthesia, 1 deep vein thrombosis, 1 deep space infection, and 1 instance of patellar tendonitis. In terms of revisions, the BKA group required 7 revisions, whereas the TKA group required only 2 revisions. In the BKA group, 3 revisions were due to implant fracture, 3 were due to persistent pain, and 1 was due to a traumatic periprosthetic fracture. In the TKA group, 1 revision was due to infection requiring poly exchange, and 1 was due to loosening of the tibial component. Nonetheless, when studies using monolithic BKA implants were removed from the analysis, both BKA and TKA had 1 revision.Figure 3Intraoperative blood loss.Figure 4Operation length.

Discussion {#sec4}
==========

The objective of this study was to assess knee joint function and perioperative morbidity in patients undergoing BKA vs TKA for MPFOA. The results of our meta-analysis do not support our hypothesis that BKA is superior to TKA. In fact, there were largely no differences in terms of functional or clinical knee outcomes between both groups at all time points. As expected, BKA did result in decreased blood loss compared with TKA, likely secondary to its bone and ligament preserving qualities. This was in keeping with results of Yeo et al. [@bib16], where this clinically significant intraoperative blood loss led to a higher rates of blood transfusion in patients undergoing TKA. However, this resulted in BKA having longer operation lengths compared with TKA. This was likely due to 2 major factors, which include the increased complexity of BKA procedures, as well as surgeon unfamiliarity with BKA implants and surgical technique due to its limited use.

In regard to postoperative complications and revisions, both groups were similar, when monolithic BKA implants were removed from the analysis. It became apparent during our study that monolithic BKA implants had a considerably higher rate of revision and failure than their modular counterparts. This was in keeping with the results of Palumbo et al. [@bib19], which similarly showed an unacceptable revision rate in monolithic implants. This was thought to be due to 2 main issues. The first issue was material failure resulting in prosthesis fracture, which eventually resulted in the implant being recalled. The second issue was difficulty aligning the distal femoral and trochlear surface simultaneously due to limited sizing options and anatomical variations. Based on this study, BKA and TKA had comparable survivability and complication rates at 2-5 years. More long-term data are needed to evaluate the true survivability of modular BKA implants, but some studies have shown near 80% survivorship of BKA at 17 years [@bib20]. The problem with assessing BKA survivability is that younger patients often choose this implant because of its conservative and joint preserving nature. As such, these patients continue long active lifestyles, making revision likely due to loosening, fracture, and normal wear.

There was a trend for newer studies to show more positive effect of BKA compared with the older studies. In particular, Parratte et al. [@bib13] and Yeo et al. [@bib16] were the two most recent studies included in this analysis, and both prospective studies had similar inclusion and exclusion criteria, homogenous baseline groups, and low risk of bias using the GRADE approach. In the aforementioned studies, patients in the BKA group had significantly higher KSS knee, KSS function, University of California Los Angeles score, KOOS score, SF-36 score, and were 4 times more likely to achieve forgotten knee status. Conversely, many of the older studies and retrospective cohorts often failed to show any clinical or functional differences between both groups. As such, the results of our study may have underestimated the true effect of BKA given the results of these high-quality studies.

The major limitation of this review was the lack of studies and the low follow-up time length. This can likely be attributed to recent development and use of BKA implants, as well as the reluctance to adopt it given the overwhelming efficacy and evidence for the use of TKA instead. A further limitation was the lack of raw data. An attempt was made to contact authors of each study for their original data; however, given no responses, we had to use the available data and comparable statistics from other studies to achieve the most accurate results. Originally, we had hoped to only include clinical trials; however, given the sparsity of data, we chose to include retrospective studies as well, which increases the possible risk for selection bias. Nonetheless, strengths of this study include the fact that this is the only meta-analysis of this topic in the literature that we are currently aware of. In addition, all the studies included for analysis have been published relatively recently between 2011 and 2015.

Conclusions {#sec5}
===========

The use of modular BKA for MPFOA is comparable with TKA in terms of short-term function, complication rate, and revision rate. Modular BKA can be an effective bone and ligament preserving procedure; however, preservation of native joint kinematics does not necessarily translate to improved clinical outcomes compared with TKA. BKA reduces intraoperative blood losses, but it is also more technically demanding, resulting in increased operation length. The use of modular BKA has acceptable short-term outcomes, but more long-term data are needed before it can be recommended for routine use in the treatment of MPFOA. The selection of modular BKA should be determined on a patient-specific basis. Currently, there is no evidence to suggest the use of monolithic BKA designs because of their high revision rate.
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==============================

Conflict of Interest Statement for ClarkConflict of Interest Statement for JohalConflict of Interest Statement for KoonerAppendices 1-3

No author associated with this paper has disclosed any potential or pertinent conflicts which may be perceived to have impending conflict with this work. For full disclosure statements refer to [http://dx.doi.org/10.1016/j.artd.2017.02.006](10.1016/j.artd.2017.02.006){#intref0010}.

Supplementary data related to this article can be found at <http://dx.doi.org/10.1016/j.artd.2017.02.006>

[^1]: BMI, body mass index; RCT, randomized controlled trial.

[^2]: Age and BMI are presented as mean (standard deviation).

[^3]: Mean difference was calculated by using the formula BKA~mean~ − TKA~mean~.

[^4]: Indicates significance.
